We predict some essential interactions between the V2 vasopressin rena
l receptor (V2R) and its selective peptide antagonist desGly(9)-[Mca(1
),D-Ile(2),Ile(4)]AVP, and compare these predictions with the earlier
ones for the non-peptide OPC-36120 antagonist-and the [Arg(8)]vasopres
sin (AVP) agonist-V2 receptor interactions. V2R controls antidiuresis
in mammals and belongs to the superfamily of the heptahelical transmem
brane (7TM) G protein-coupled receptors (GPCR)s. V2R was built, the li
gands docked and the structures relaxed using advanced molecular model
ing techniques. Both the agonist and the antagonists (no matter whethe
r of peptide- or non-peptide type) appear to prefer a common V2R compa
rtment for docking. The receptor aminoacid residues, potentially impor
tant in ligand binding, are mainly in the TM3-TM7 helices. A few of th
ese residues are invariant for the whole GPCR superfamily while most o
f them are conserved in the subfamily of neurohypophyseal receptors, t
o which V2R belongs. Some of the equivalent residues in a related V1a
receptor have been earlier reported as critical for the ligand affinit
y.